{"id":"W3018981957","doi":"10.1186/s13223-020-00419-z","title":"Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy","year":2020,"lang":"en","type":"article","venue":"Allergy Asthma and Clinical Immunology","topic":"Food Allergy and Anaphylaxis Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Institut Universitaire en Santé Mentale de Québec; Hospital for Sick Children; SickKids Foundation; University of Toronto; Centre Hospitalier de l’Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research; Novartis Pharmaceuticals Canada","keywords":"Omalizumab; Dosing; Medicine; Placebo; Dose; Oral immunotherapy; Maintenance dose; Randomized controlled trial; Allergy; Surgery; Food allergy; Internal medicine; Immunology; Immunoglobulin E; Antibody","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002228325,0.0003060435,0.002464824,0.0001368709,0.0001059123,0.00001931018,0.000300836,0.0005309249,0.000423933],"category_scores_gemma":[0.002626858,0.0001706436,0.001048666,0.0002979459,0.0009525271,0.00004181001,0.00008948765,0.0009214735,0.00001681171],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001602729,"about_ca_system_score_gemma":0.0002364124,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004527202,"about_ca_topic_score_gemma":0.0000643787,"domain_scores_codex":[0.9954474,0.001382709,0.00198657,0.000510715,0.000242293,0.000430335],"domain_scores_gemma":[0.9942001,0.004667707,0.0004634961,0.0003712243,0.0001728582,0.0001246786],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9773775,0.002775718,0.00001072495,0.00002242013,0.004451625,0.00001175182,0.0002344622,0.00000760228,0.0003532827,0.008432478,0.00006915582,0.006253314],"study_design_scores_gemma":[0.9620823,0.02289707,0.0007219946,0.00008917463,0.00001552901,0.00000532277,0.00009210539,0.001465257,0.0001560246,0.0001694502,0.01214873,0.0001571016],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6825748,0.0003573524,0.00009366578,0.01609026,0.0002353053,0.2996424,0.000004152911,0.00005772178,0.0009442794],"genre_scores_gemma":[0.8198566,0.0002850524,0.000167772,0.0009991452,0.0001395519,0.1780504,0.00001877841,0.00004719607,0.0004354884],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1372818,"threshold_uncertainty_score":0.6958644,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1281026521262575,"score_gpt":0.4266244699684372,"score_spread":0.2985218178421797,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}